Table 1: Baseline clinical characteristics of the study participants.

ParametersGroup A
()
Group B
()
P value

Sex (M/F)19/628/120.599
Age (years)53.76 ± 8.8949.10 ± 10.570.071
BMI (kg/m2)26.46 ± 4.6024.63 ± 3.710.083
SBP (mmHg)125.00 ± 7.65123.63 ± 9.000.529
DBP (mmHg)74.24 ± 8.7473.75 ± 6.130.808
FBG (mmol/L)7.43 ± 1.015.06 ± 0.50<0.001
TC (mmol/L)4.62 ± 0.664.49 ± 0.740.461
HDL (mmol/L)1.25 ± 0.291.61 ± 0.29<0.001
LDL (mmol/L)2.80 ± 0.532.45 ± 0.620.023
TG (mmol/L)3.05 ± 0.860.92 ± 0.37<0.001
HbA1c (%)6.88 ± 0.725.42 ± 0.33<0.001

Group A, type 2 diabetes mellitus patients with hypertriglyceridemia; group B, control subjects; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; HbA1c, glycosylated hemoglobin.